MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511115503 A) filed by Nims University, Jaipur, Rajasthan, on Nov. 22, 2025, for 'a transdermal patch for the management of myocardial infarction.'
Inventor(s) include N Swetapadma Rout; Divyamol Jose; Prerna Pandey; and Dr. Prashant Nakash.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The invention provides a multifunctional transdermal patch (101) for the emergency management of acute myocardial infarction. The patch (101) comprises a flexible, impermeable backing layer (102), a drug-in-adhesive matrix (103) containing a rapid-acting antiplatelet agent, a fast-acting vasodilator, and a secondary antiplatelet agent, a removable release liner (104), a visual indicator (105), and an integrated biosensor (106) for monitoring vital signs. The invention also provides a method of using the patch (101), wherein the release liner (104) is removed and the patch applied to the patient skin to achieve immediate release of the rapid-acting agents and controlled, sustained release of the secondary antiplatelet agent over several hours. This dual-action delivery provides rapid inhibition of platelet aggregation, prompt symptomatic relief, and prolonged antiplatelet effect, maintaining therapeutic plasma concentrations during the critical pre-hospital period, thereby addressing the limitations of conventional oral or sublingual drug administration in cardiac emergencies."
Disclaimer: Curated by HT Syndication.
